Citation	Subject	Subject Label	Predicate	Object	Object Label	Qualifier	Qualifier Label	Subject Qualifier	Subject Extension	Object Extension	Count
38423591	targeted approach		treats	no specific symptom		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		elexacaftor/tezacaftor/ivacaftor		1
38469782	development of a low cost semiquantitative polymerase chain reaction assay		treats	diagnostic uncertainty		williams beuren syndrome		low cost	semiquantitative polymerase chain reaction assay		1
38469782	molecular diagnosis		treats	diagnostic uncertainty		williams beuren syndrome					1
38469782	maxo:0009004	whole exome sequencing	treats	diagnostic uncertainty		mondo:0008678	williams beuren syndrome (wbs)				1
38469782	fluorescence in-situ hybridization (fish)		treats	diagnostic uncertainty		mondo:0008678	williams beuren syndrome (wbs)		fluorescence in-situ hybridization		1
38422338	modified incremental step test (mist)		treats	disease severity		non-cystic fibrosis bronchiectasis					1
38422338	modified incremental step test (mist)		treats	hp:0012378	fatigue	non-cystic fibrosis bronchiectasis					1
38422338	modified incremental step test (mist)		treats	hp:0002094	dyspnea	non-cystic fibrosis bronchiectasis					1
38422338	modified incremental step test (mist)		treats	leg fatigue		non-cystic fibrosis bronchiectasis					1
38422338	modified incremental step test (mist)		treats	desaturation		non-cystic fibrosis bronchiectasis					1
38307319	hfcwo therapy		treats	retained pulmonary secretions		bronchiectasis		high frequency	high frequency chest wall oscillation		1
38307319	hfcwo therapy		treats	exacerbations		bronchiectasis		high frequency	high frequency chest wall oscillation		1
38307319	high frequency chest wall oscillation (hfcwo) therapy		prevents	hospitalizations		bronchiectasis					1
38154821	improved recognition of lung function decline		prevents	worsening respiratory status		mondo:0009061	cystic fibrosis				1
38154821	treatment		treats	worsening respiratory status		mondo:0009061	cystic fibrosis				1
38154821	follow-up		treats	worsening respiratory status		mondo:0009061	cystic fibrosis				1
38154821	screening and recognition		prevents	decline in forced expiratory volume in one second (fev1)		mondo:0009061	cystic fibrosis				1
38154821	a treatment algorithm		treats	decline in forced expiratory volume in one second (fev1)		mondo:0009061	cystic fibrosis				1
38362632	prolonged-infusion		treats	in		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		chebi:35627		1
38231535	overexpression		reduces	increased susceptibility		mondo:0005545	staphylococcus aureus		nora (efflux pump)	pyocyanin killing	1
38231535	use of reserpine		increases	increased susceptibility to pyocyanin killing		staphylococcus aureus			reserpine		1
38231535	well diffusion assay		measures	larger pyo-created inhibition zone		mondo:0005545	staphylococcus aureus				1
38133654	liver magnetic resonance elastography		treats	liver stiffness		mondo:0009061	cystic fibrosis				1
38133654	liver magnetic resonance spectroscopy		treats	hepatosteatosis		mondo:0009061	cystic fibrosis				1
38133654	noninvasive assessment of liver involvement		treats	liver stiffness		mondo:0009061	cystic fibrosis				1
38133654	noninvasive assessment of liver involvement		treats	hepatosteatosis		mondo:0009061	cystic fibrosis				1
38269412	developed updated algorithms		treats	overestimated co2 signal		signal-correction errors in easyone pro lab device					1
38269412	developed updated algorithms		treats	signal-correction errors		easyone pro lab device			easyone pro lab device	uncorrected dependence on humidity	1
38269412	assessed impact on mbw outcomes and frc measurement accuracy		treats	increased difference in frc		signal-correction errors			easyone pro lab device	between eopl and body plethysmography	1
38379863	continuous glucose monitoring		treats	hyperglycemia		cystic fibrosis-related diabetes		continuous	glucose monitoring		1
38379863	continuous glucose monitoring		treats	glycemic variability		cystic fibrosis-related diabetes		continuous	glucose monitoring		1
38379863	2-hour oral glucose tolerance testing (ogtt)		treats	hyperglycemia		cystic fibrosis-related diabetes		null	oral glucose tolerance testing	null	1
38379863	hemoglobin a1c (hba1c) measurement		treats	hyperglycemia		cystic fibrosis-related diabetes					1
38379863	skin autoflurescence		treats	hp:0003074	hyperglycemia	cystic fibrosis-related diabetes			chebi:84123		1
38379863	eti use		prevents	pulmonary decline		cystic fibrosis-related diabetes			elexacaftor/tezacaftor/ivacaftor		1
38379863	use		prevents	weight decline		cystic fibrosis-related diabetes			chebi:53454	weight decline	1
38153868	use of elexacaftor + tezacaftor + ivacaftor (eti)		prevents	decline in lung function		mondo:0009061	cystic fibrosis		chebi:53454		1
38153868	discontinuation		treats	respiratory symptoms		mondo:0009061	cystic fibrosis		dornase alfa		1
38153868	discontinuation of hypertonic saline		treats	respiratory symptoms		cystic fibrosis			hypertonic saline		1
38153868	intermittent use of dornase alfa for symptom relief		treats	respiratory symptoms		mondo:0009061	cystic fibrosis	intermittent	dornase alfa		1
38153868	intermittent use of hypertonic saline for symptom relief		treats	respiratory symptoms		mondo:0009061	cystic fibrosis	intermittent	hypertonic saline		1
38287360	evaluation		treats	chronic bronchopulmonary infections		mycobacterium abscessus pulmonary infections			arenicin peptides		1
38287360	insertion into mycobacterial lipids		treats	chronic bronchopulmonary infections		mycobacterium abscessus pulmonary infections		with arenicin peptides	arenicin peptides		1
38310629	dose adjustment		treats	forced expiratory volume in the first second (fev1) decrease		mondo:0009061	cystic fibrosis				1
38310629	therapeutic drug monitoring		treats	forced expiratory volume in the first second (fev1) decrease		cystic fibrosis			therapeutic drug monitoring		1
38394229	combination treatment to improve mucociliary transport		treats	accumulation of hyperconcentrated mucus		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		combination treatment		1
38394229	disulfide bond reducing agent application		treats	biofilm resistance		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with tris(2-carboxyethyl)phosphine	chebi:50329		1
38394229	surfactant application		treats	mucus accumulation and obstruction		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with np40	chebi:63016		1
38394229	biopolymer application		treats	chronic inflammation		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with hyaluronic acid	chebi:16336		1
38394229	dna degradation enzyme application		treats	infection		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with dnase	dnase		1
38394229	antibiotic administration		treats	hp:0011947	respiratory infections	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with tobramycin	chebi:28864	acute or chronic	1
38350918	prospective study		prevents	increased risk of future severe exacerbations		mondo:0004822	bronchiectasis				1
38350918	obtained baseline serum hs-crp		treats	reduced lung function		mondo:0004822	bronchiectasis	with hs-crp	hs-crp		1
38350918	follow-up		prevents	increased risk of future severe exacerbations		mondo:0004822	bronchiectasis				1
38377145	spirometric lung function tests		treats	diagnosis		mondo:0004979	asthma	n/a	n/a	n/a	1
38377145	plethysmographic lung function tests		treats	diagnosis		mondo:0011751	copd				1
38377145	spirometric lung function tests		treats	diagnosis		asthma-copd overlap					1
38377145	lung function tests		treats	diagnosis		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		plethysmographic		1
38377145	linear discriminant analyses		prevents	misclassification		obstructive lung diseases			linear discriminant analyses		1
38377145	recursive partitioning decision trees		prevents	misclassification		obstructive lung diseases			recursive partitioning decision trees		1
38253430	sweat induction and collection		treats	insufficient sweat volume		mondo:0009061	cystic fibrosis				1
38253430	sweat induction and collection		treats	insufficient sweat volume		mondo:0009061	cystic fibrosis	with	pilocarpine gel		1
38088678	spirometry		treats	obstructive ventilatory disorders		mondo:0009061	cystic fibrosis				1
38088678	impulse oscillometry		treats	compromised peripheral airways		mondo:0009061	cystic fibrosis				1
38426679	use of cftr modulators		treats	reduced appetite		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with ivacaftor-tezacaftor-elexacaftor	cftr modulators (with ivacaftor-tezacaftor-elexacaftor)		1
38426679	use of cftr modulators		prevents	low body mass index		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with ivacaftor-tezacaftor-elexacaftor	cftr modulators	ivacaftor-tezacaftor-elexacaftor	1
38426679	use of cftr modulators		treats	pulmonary exacerbations		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)	with ivacaftor-tezacaftor-elexacaftor	cftr modulators	ivacaftor-tezacaftor-elexacaftor	1
38426679	dose adjustment		prevents	alterations of the liver function		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38426679	clinical and laboratoristic monitoring of hepatic function		prevents	alterations of the liver function		cystic fibrosis					1
38092672	sequencing of strains		prevents	resistance		mondo:0009061	cystic fibrosis		murepavadin, colistin, tobramycin		1
38092672	allelic replacement experiments		treats	susceptibility issues		mondo:0009061	cystic fibrosis		murepavadin		1
38286409	monitoring tobramycin trough levels		prevents	increased tobramycin trough levels		mondo:0009061	cystic fibrosis		chebi:28864		1
38286409	intravenous tobramycin treatment		treats	pseudomonas aeruginosa infection		mondo:0009061	cystic fibrosis	with tobramycin	chebi:28864		1
38286409	adjustment of tobramycin dosage		prevents	increased tobramycin trough levels		mondo:0009061	cystic fibrosis		chebi:28864		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection					1
38336730	next-generation genome sequencing		prevents	lung infections		pseudomonas aeruginosa infection			next-generation genome sequencing		1
38336730	epidemiological investigation		prevents	lung infections		pseudomonas aeruginosa infection			epidemiological investigation		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with colistin	chebi:37943		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with amikacin	chebi:2637		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with gentamicin	chebi:17833		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with ceftazidime	chebi:3508		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with piperacillin	chebi:8232		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with piperacillin-tazobactam	piperacillin-tazobactam		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with ciprofloxacin	chebi:100241		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with meropenem	chebi:43968		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with aztreonam	chebi:161680		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with imipenem	chebi:471744		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aeruginosa infection		with cefepime	chebi:478164		1
38336730	antimicrobial susceptibility determination		treats	hp:0006532	lung infections	pseudomonas aerugin		with levofloxacin	chebi:63598		1
38206973	spirometry		treats	impaired mucociliary clearance		mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)		spirometry		1
38206973	spirometry		treats	impaired mucociliary clearance		mondo:0009061	cystic fibrosis		spirometry		1
38206973	multiple-breath washout		treats	impaired mucociliary clearance		mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)				1
38206973	multiple-breath washout		treats	impaired mucociliary clearance		mondo:0009061	cystic fibrosis				1
38206973	magnetic resonance imaging (mri)		treats	chronic progressive lung disease		mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)				1
38206973	magnetic resonance imaging (mri)		treats	chronic progressive lung disease		mondo:0009061	cystic fibrosis				1
38206973	magnetic resonance imaging		treats	chronic rhinosinusitis		primary ciliary dyskinesia			mri		1
38206973	magnetic resonance imaging		treats	hp:0011109	chronic rhinosinusitis (crs)	mondo:0009061	cystic fibrosis				1
38206973	magnetic resonance imaging		treats	consolidations		mondo:0016575	primary ciliary dyskinesia				1
38109903	reanalysis of mbw data		treats	lung disease		cystic fibrosis			mbw data		1
38109903	antibiotic therapy		treats	pulmonary exacerbation		cystic fibrosis			antibiotic		1
38109903	reanalysis of mbw data		treats	pulmonary exacerbation		mondo:0009061	cystic fibrosis	with nitrogen	chebi:25555		1
38266939	development of inhaled dry powder		treats	chronic lower respiratory tract infection		chronic lower respiratory tract infection			liposomal azithromycin		1
38266939	antimicrobial activity assays		treats	chronic lower respiratory tract infection		chronic lower respiratory tract infection		with azithromycin	chebi:2955		1
38266939	cytotoxicity and cellular uptake studies		prevents	adverse effects		chronic lower respiratory tract infection					1
38059634	intermittent dosing		treats	hp:0006532	lung infections	mondo:0009061	cystic fibrosis		chebi:28001		1
38059634	pharmacokinetics characterization		treats	hp:0006532	lung infections	mondo:0009061	cystic fibrosis	with vancomycin	chebi:28001		1
38059634	therapeutic monitoring		treats	hp:0006532	lung infections	mondo:0009061	cystic fibrosis	with vancomycin	chebi:28001		1
38059634	monte carlo simulations		prevents	toxicity		mondo:0009061	cystic fibrosis	with vancomycin	chebi:28001		1
38059634	target attainment analysis		treats	hp:0006532	lung infections	mondo:0009061	cystic fibrosis	with vancomycin	chebi:28001		1
38411018	maxo:0000624	nutritional assessment	prevents	hp:0004395	malnutrition	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38411018	body composition analysis		prevents	hp:0004395	malnutrition	mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38411018	elx/tez/iva therapy		treats	worsening of pulmonary function		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)		elexacaftor-tezacaftor-ivacaftor		1
38400672	kidney transplantation		treats	cystic fibrosis							1
38400672	peri-operative morbidity management		prevents	peri-operative complications		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38400672	acute graft rejection intervention		treats	acute graft rejection		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38400672	delayed graft function management		treats	delayed graft function		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38169359	maxo:0000530	carrier screening	prevents	birth of child with cystic fibrosis		mondo:0009061	cystic fibrosis				1
38214406	habitual physical activity		prevents	reduced hrqol		mondo:0009061	cystic fibrosis				1
38214406	exercise capacity evaluation		treats	reduced exercise capacity		mondo:0009061	cystic fibrosis				1
38214406	lung function tests		treats	reduced forced expiratory volume in 1 s (ppfev1)		mondo:0009061	cystic fibrosis				1
38214406	body mass index (bmi) calculation		treats	reduced hrqol		mondo:0009061	cystic fibrosis				1
38214406	activity measurement		prevents	sedentary behavior		cystic fibrosis		accelerometer use	accelerometer		1
38214406	bicycle ergometry for maximal exercise capacity assessment		treats	reduced exercise capacity		mondo:0009061	cystic fibrosis				1
38214406	cystic fibrosis questionnaire-revised (cfq-r) response analysis		treats	reduced hrqol		cystic fibrosis		n/a	n/a	n/a	1
38169175	supplementation		prevents	nutritional status deterioration		cystic fibrosis			vitamins		1
38169175	supplementation		treats	nutritional status deterioration		mondo:0009061	cystic fibrosis		pancreatic enzymes		1
38169175	management of nutritional status		prevents	nutritional status deterioration		mondo:0009061	cystic fibrosis				1
38169175	nutrition after organ transplantation		treats	nutritional status deterioration		mondo:0009061	cystic fibrosis				1
38168683	combination testing		treats	biofilms		mondo:0009061	cystic fibrosis	with polymyxin b and ethylenediaminetetraacetic acid	polymyxin b, ethylenediaminetetraacetic acid		1
38168683	management of biofilm-associated conditions		treats	biofilms		mondo:0009061	cystic fibrosis				1
38168683	antimicrobial therapy		treats	biofilms		mondo:0009061	cystic fibrosis	with polymyxin b and ethylenediaminetetraacetic acid	polymyxin b and ethylenediaminetetraacetic acid		1
38168683	antibiofilm therapy		treats	biofilms		mondo:0009061	cystic fibrosis	with polymyxin b and ethylenediaminetetraacetic acid	polymyxin b and ethylenediaminetetraacetic acid		1
38251578	covid-19 vaccine booster doses		prevents	no detectable igg anti-spike antibodies		mondo:0100096	covid-19		covid-19 vaccine booster doses	no detectable igg anti-spike antibodies	1
38251578	antibody testing		treats	no detectable igg anti-spike antibodies		mondo:0100096	covid-19	using	lateral flow immunoassay tests		1
38251578	immunosuppressive medication		prevents	no detectable igg anti-spike antibodies		mondo:0100096	covid-19	with anti-proliferative agent	anti-proliferative agent		1
38251578	immunosuppressive medication		prevents	no detectable igg anti-spike antibodies		mondo:0100096	covid-19	with	chebi:37153		1
38251578	immunosuppressive medication		prevents	no detectable igg anti-spike antibodies		mondo:0100096	covid-19	with steroids	chebi:35341		1
38251578	immunosuppressive medication		prevents	no detectable igg anti-spike antibodies		mondo:0100096	covid-19	with anti-cd20 therapies	anti-cd20 therapies		1
38426830	cardiopulmonary exercise testing		treats	advanced cystic fibrosis lung disease							1
38458782	standardising iswt performance		treats	reduced exercise capacity		mondo:0009061	cystic fibrosis				1
38458782	standardising iswt performance		treats	reduced exercise capacity		haemophilia			iswt		1
38458782	evaluating iswt performance against paediatric normative reference equation		treats	reduced exercise capacity		mondo:0009061	cystic fibrosis		iswt		1
38458782	evaluating iswt performance		treats	reduced exercise capacity		haemophilia		against paediatric normative reference equation	iswt	paediatric normative reference	1
38458782	association assessment between standardised iswt performance		treats	disease severity		cystic fibrosis		standardised	iswt		1
38458782	association assessment		treats	disease severity		haemophilia		standardised	iswt		1
38458782	linear regression analysis		prevents	disease severity		mondo:0009061	cystic fibrosis				1
38458782	linear regression analysis		prevents	disease severity		haemophilia					1
38233941	intravenous (iv) antibiotic therapy		treats	pulmonary exacerbation		cystic fibrosis		intravenous (iv)	antibiotic		1
38233941	multiple breath washout (mbw) evaluation		assesses	pulmonary exacerbation		cystic fibrosis		na	na	na	1
38233941	spirometry		assesses	pulmonary exacerbation		mondo:0009061	cystic fibrosis				1
38114870	whole-exome sequencing		prevents	hp:0000027	azoospermia	congenital obstructive azoospermia					1
38114870	semen parameters evaluation		treats	hp:0000027	azoospermia	congenital obstructive azoospermia					1
38114870	sex hormones evaluation		treats	hp:0000027	azoospermia	congenital obstructive azoospermia			sex hormones evaluation		1
38114870	seminal plasma biochemistry evaluation		treats	hp:0000027	azoospermia	congenital obstructive azoospermia					1
38114870	surgical sperm extraction-intracytoplasmic sperm injection (icsi) treatment		treats	hp:0000027	azoospermia	congenital obstructive azoospermia					1
38114870	maxo:0000079	genetic counseling	prevents	hp:0000027	azoospermia	congenital obstructive azoospermia					1
38309533	stepwise algorithm incorporation		prevents	overuse of ogtt		cystic fibrosis-related diabetes					1
38309533	composite index		prevents	overuse of ogtt		cystic fibrosis-related diabetes		with hba1c, homa2	dipic formulation		1
38128948	bilateral lung transplantation		treats	cystic fibrosis		paediatric cystic fibrosis					1
38128948	maxo:0001351	occupational therapy	treats	"""big problems"" with self-care tasks"		mondo:0009061	cystic fibrosis				1
38128948	maxo:0001351	occupational therapy	treats	family engagement issues		mondo:0009061	cystic fibrosis				1
38128948	maxo:0001351	occupational therapy	treats	coping with worries		mondo:0009061	cystic fibrosis				1
38128948	maxo:0001351	occupational therapy	treats	issues with community engagement		mondo:0009061	cystic fibrosis				1
38128948	maxo:0001351	occupational therapy	treats	problems with independence		mondo:0009061	cystic fibrosis				1
38296344	systemic antibiotic treatment		treats	p. aeruginosa infection		bronchiectasis			antibiotic		1
38296344	inhaled antibiotic treatment		treats	p. aeruginosa infection		mondo:0004822	bronchiectasis	inhaled	chebi:33281		1
38296344	combined systemic and inhaled antibiotic treatment		treats	p. aeruginosa infection		mondo:0004822	bronchiectasis	with antibiotics	chebi:33281		1
38184455	bronchial artery embolisation		treats	hp:0002105	haemoptysis	mondo:0009061	cystic fibrosis				1
38184455	imaging symptomatic patients		prevents	neurovascular complications		mondo:0009061	cystic fibrosis				1
38254935	genetic monitoring		prevents	azoospermia-related male infertility		mondo:0009061	cystic fibrosis		genetic monitoring		1
38254935	genotyping		treats	azoospermia-related male infertility		mondo:0009061	cystic fibrosis		genotyping		1
38346040	ceragenin csa-13 (with dnase i) treatment		treats	elevated viscosity and elasticity		mondo:0009061	cystic fibrosis	with dnase i	ceragenin csa-13		1
38346040	ceragenin csa-13 (with poly-aspartic acid (pasp))		treats	elevated viscosity and elasticity		mondo:0009061	cystic fibrosis		ceragenin csa-13		1
38268067	8-week remotely supervised resistance training program		treats	reduced muscle strength		mondo:0009061	cystic fibrosis				1
38268067	8-week remotely supervised resistance training program		treats	altered body composition		cystic fibrosis			resistance training		1
38275615	genetic screening		prevents	hp:0001263	developmental delay	mondo:0012084	aromatic l-amino acid decarboxylase deficiency (aadcd)				1
38275615	molecular investigation		prevents	undiagnosed neurological disorders		aromatic l-amino acid decarboxylase deficiency (aadcd)					1
38441982	use of hnp-1 and hbd-3		treats	multidrug-resistant eskape gram-negatives		multidrug-resistant eskape gram-negatives			hnp-1 and hbd-3		1
38441982	combination with lysozyme		treats	multidrug-resistant eskape gram-negatives		multidrug-resistant eskape gram-negatives			lysozyme		1
38441982	combination with colistin		treats	multidrug-resistant eskape gram-negatives		multidrug-resistant eskape gram-negatives		with colistin	colistin		1
38441982	combination with meropenem		treats	multidrug-resistant eskape gram-negatives		multidrug-resistant eskape gram-negatives		with meropenem	chebi:43968		1
38132670	genomic analyses		treats	p. aeruginosa lung infection		patient					1
38431897	maxo:0000118	immunization	prevents	covid-19 infection		mondo:0009061	asthma; copd; asthma-copd overlap; cystic fibrosis (cf)				1
38057039	initialization of elexacaftor-tezacaftor-ivacaftor therapy		treats	hp:0004395	malnutrition	mondo:0009061	cystic fibrosis		elexacaftor-tezacaftor-ivacaftor		1
38057039	initialization of therapy		treats	cystic fibrosis related diabetes (cfrd)		mondo:0009061	cystic fibrosis		elexacaftor-tezacaftor-ivacaftor		1
38057039	initialization of elexacaftor-tezacaftor-ivacaftor therapy		treats	hp:0040270	impaired glucose tolerance (igt)	mondo:0009061	cystic fibrosis		elexacaftor-tezacaftor-ivacaftor		1
38057039	reduction or cessation of insulin therapy		treats	cystic fibrosis related diabetes (cfrd)		mondo:0009061	cystic fibrosis		chebi:145810		1
38054992	annual follow-up		prevents	progression to cystic fibrosis		cfspid					1
38054992	evaluation of sweat chloride values		treats	pathological sweat chloride values (>= 60 mmol/l)		cystic fibrosis					1
38054992	assessment of lung function		prevents	lung dysfunction		mondo:0009061	cystic fibrosis				1
38054992	diagnosis of cf or cftr-related disorders		treats	multi-organ involvement		mondo:0009061	cystic fibrosis				1
38054992	annual follow-up		prevents	progression to cystic fibrosis		cfspid		with assessment of abnormal lci2.5			1
38135160	targeted drug delivery to the pulmonary system		treats	hp:0002094	difficulty breathing	mondo:0009061	cystic fibrosis				1
38135160	targeted drug delivery to the pulmonary system		treats	large accumulation of mucus in the respiratory tract		mondo:0009061	cystic fibrosis				1
38135160	maxo:0001298	therapy	treats	serious bacterial infections		mondo:0009061	cystic fibrosis		nanoparticle-based		1
38135160	traditional drug-based treatments		treats	difficulty breathing		cystic fibrosis			traditional drug-based treatments		1
38135160	traditional drug-based treatments		treats	large accumulation of mucus in the respiratory tract		mondo:0009061	cystic fibrosis		traditional drug-based treatments		1
38236037	use of amikacin		treats	growth of mycobacterium abscessus		mycobacterium abscessus pulmonary disease			chebi:2637		1
38236037	short-interval dosing		treats	growth of mycobacterium abscessus		mycobacterium abscessus pulmonary disease		with amikacin	chebi:2637		1
38236037	short-interval dosing		prevents	resistance emergence		mycobacterium abscessus pulmonary disease		with amikacin	chebi:2637		1
38236037	extended-interval dosing		treats	growth of mycobacterium abscessus		mycobacterium abscessus pulmonary disease		with amikacin	chebi:2637		1
38236037	extended-interval dosing		fails to prevent	resistance emergence		mycobacterium abscessus pulmonary disease		with amikacin	chebi:2637		1
38179878	retrospective study		treats	changes in body mass index		mondo:0009061	cystic fibrosis				1
38179878	retrospective study		treats	changes in serum lipids		cystic fibrosis					1
38179878	retrospective study		treats	changes in fat-soluble vitamin levels		cystic fibrosis					1
38179878	elexacaftor/tezacaftor/ivacaftor (eti) therapy		treats	changes in body mass index		mondo:0009061	cystic fibrosis		chebi:53454		1
38179878	maxo:0001298	therapy	treats	changes in serum lipids		mondo:0009061	cystic fibrosis		chebi:53454		1
38272397	maxo:0001001	gene therapy	treats	mutations in the cf transmembrane conductance regulator (cftr) gene		mondo:0009061	cystic fibrosis				1
38272397	gene delivery vectors		treats	mutations		mondo:0009061	cystic fibrosis		highly branched poly(beta-amino ester) (hpae)	mutations in the cf transmembrane conductance regulator (cftr) gene	1
38272397	backbone cationization strategy		treats	lung cystic fibrosis (cf)		mondo:0009061	cystic fibrosis		backbone cationization strategy	mutations in the cf transmembrane conductance regulator (cftr) gene	1
38272397	reinstatement of cftr protein expression		treats	dysfunctional cftr protein		mondo:0009061	cystic fibrosis	with 1-(3-aminopropyl)-4-methylpiperazine (e7)	1-(3-aminopropyl)-4-methylpiperazine (e7)		1
38386889	pancreatic enzyme replacement therapy (pert)		treats	low fecal elastase-1 levels		mondo:0001684	exocrine pancreatic insufficiency (epi)		pancreatic enzyme replacement therapy		1
38088381	measurement of nasal nitric oxide		prevents	misdiagnosis		mondo:0016575	primary ciliary dyskinesia				1
38088381	use of chemiluminescence device		treats	diagnostic challenges		primary ciliary dyskinesia			chemiluminescence		1
38088381	use of devices based on electrochemical sensors		treats	diagnostic challenges		mondo:0008932	primary ciliary dyskinesia (pcd) and cystic fibrosis (cf)		electrochemical sensors		1
38088381	following standardized guidelines		prevents	diagnostic errors		primary ciliary dyskinesia		not applicable	not applicable	not applicable	1
38291686	harmonizing the description		prevents	variations		cfhbi					1
38291686	providing a reliable account		treats	hepatobiliary involvement		cfhbi					1
38291686	supporting the development of clinical outcomes		treats	hepatobiliary involvement		cfhbi					1
38291686	developing a systematic classification		prevents	variations					cfhbi		1
38291686	achieving validation for clinical practice and research		prevents	inaccuracies		cfhbi		na	cfhbi	na	1
38179886	modulator therapy		treats	cystic fibrosis							1
38179886	mbnw		assesses	small airway disease (sad)		mondo:0009061	cystic fibrosis				1
38179886	spirometry		assesses	hp:0006536	airway obstruction	mondo:0009061	cystic fibrosis				1
38356031	pulmonary drug delivery		treats	respiratory disorders		respiratory disorders			pulmonary drug delivery		1
38356031	local targeting to the lungs		treats	respiratory disorders		respiratory disorders					1
38356031	noninvasive pulmonary delivery		prevents	systemic side effects		respiratory disorders		noninvasive	pulmonary delivery		1
38356031	systemic absorption		treats	respiratory disorders		mondo:0005087	respiratory disorders				1
38269943	application		treats	lung perfusion changes		mondo:0009061	cystic fibrosis		explainable artificial intelligence algorithms		1
38269943	application of explainable artificial intelligence algorithms		treats	mucus plugging		mondo:0009061	cystic fibrosis				1
38269943	use of deep learning-based classification pipeline		treats	lung perfusion changes		cystic fibrosis			deep learning-based classification pipeline		1
38269943	use		treats	mucus plugging		mondo:0009061	cystic fibrosis		deep learning-based classification pipeline		1
38327061	video-assisted thoracoscopic surgery (vats)		treats	postoperative pain		non-cystic fibrosis bronchiectasis in children					1
38327061	video-assisted thoracoscopic surgery (vats)		treats	intraoperative blood loss		non-cystic fibrosis bronchiectasis in children					1
38327061	video-assisted thoracoscopic surgery (vats)		treats	transfusion status		non-cystic fibrosis bronchiectasis in children					1
38327061	video-assisted thoracoscopic surgery (vats)		treats	postoperative mechanical ventilation time		non-cystic fibrosis bronchiectasis in children					1
38327061	video-assisted thoracoscopic surgery (vats)		treats	chest tube drainage time		non-cystic fibrosis bronchiectasis in children					1
38327061	video-assisted thoracoscopic surgery (vats)		treats	length of hospital stay		non-cystic fibrosis bronchiectasis in children					1
38327061	video-assisted thoracoscopic surgery (vats)		treats	incidence of complications		non-cystic fibrosis bronchiectasis in children					1
38150545	maxo:0000016	cell therapy	treats	airway epithelium injury		mondo:0009061	cystic fibrosis				1
38150545	droplet digital pcr		measures	chimerism		mondo:0009061	cystic fibrosis				1
38150545	conditionally reprogrammed cell culture methods		improve	cell engraftment efficiency		cystic fibrosis			conditionally reprogrammed cell culture methods		1
38150545	irradiating		treats	competition for space in the airway epithelium		mondo:0009061	cystic fibrosis				1
38150545	viral preconditioning		treats	airway epithelium injury		mondo:0009061	cystic fibrosis				1
38430625	continuous glucose monitoring		treats	declining lung function		cystic fibrosis related diabetes (cfrd)		with glucose	chebi:17234		1
38430625	2-h standard oral glucose tolerance testing		treats	nutritional status decline		cystic fibrosis related diabetes (cfrd)		with glucose	chebi:17234		1
38309959	methacholine challenge test (mct)		treats	hp:0032933	airway hyperresponsiveness	mondo:0004979	bronchial asthma		chebi:6804		1
38309959	inhalation of bronchodilator		treats	breathlessness				with salbutamol or ipratropium bromide	chebi:2549		1
38309959	wheezing		in	hp:0002099	bronchial asthma						1
38309959	quality control of mct equipment		prevents	inadequate inhalation		mondo:0004979	bronchial asthma		chebi:50142		1
38309959	interpreting mct results		treats	diagnosis uncertainty		mondo:0004979	bronchial asthma		mct		1
38309959	managing adverse reactions and safety measures		prevents	life-threatening situations		bronchial asthma			mct		1
38423592	targeted approach		treats	cystic fibrosis					elexacaftor/tezacaftor/ivacaftor		1
38270329	data collection		prevents	increase in body mass index (bmi)		mondo:0009061	cystic fibrosis				1
38270329	pubertal and endocrine data analysis		prevents	impaired final height		cystic fibrosis			pubertal and endocrine data analysis		1
38270329	data collection		prevents	early adrenarche		mondo:0009061	cystic fibrosis				1
38270329	pubertal and endocrine data analysis		prevents	accelerated bone age		cystic fibrosis			pubertal and endocrine data analysis		1
38070531	use of an international consensus-based core outcome set (cos)		prevents	exacerbation frequency		non-cystic fibrosis bronchiectasis			chebi:17245		1
38070531	use		prevents	non-scheduled health-care visits		non-cystic fibrosis bronchiectasis			chebi:17245		1
38070531	use of an international consensus-based core outcome set (cos)		prevents	hospitalisations		non-cystic fibrosis bronchiectasis			chebi:17245		1
